Hepatitis-B-Immunglobulin Behring, Injektionslösung - 1 ml Swissmedic Key 00674003 Registration Holder CSL Behring AG Name Hepatitis-B-Immunglobulin Behring, Injektionslösung Date of registration 01.03.2004 Introduction of Sequence 01.03.2004 ATC-Classification Hepatitis B Immunoglobulin (J06BB04) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.09. Show package size 1 ml Index Therapeuticus (Swissmedic) 08.09. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680006740037 Medication Code Blutprodukte Pharmacode Disponibility
Composition immunoglobulinum humanum hepatitidis B min. 200 U.I. corresp. immunoglobulinum humanum normale min. 95 % corresp. proteina 100-170 mg, glycinum, natrii chloridum corresp. natrium max. 1.18 mg, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. Packungsbestandteile Galenic Form Injection solution Excipiens Active Agent Dose Immunoglobulinum Humanum Hepatitidis B 200 UI/ml correspond Immunoglobulinum Humanum Normale 95 %/ml
Inactive agents Acidum Hydrochloridum Glycin Sodium Chloride Sodium Hydroxide
Source Data was imported : 06.06.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
